Combination of technologies could reduce the number of early trial compounds from millions to hundreds, potentially shaving years off the discovery-development programme.
A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists.
The Shapeshifting Inspired Discovery (SID) program decodes the structures of proteins in our cells that scientists suspect may hold the key to new treatments. The program can rapidly analyse the complicated shapes and identify how the proteins might be “shapeshifted” by drugs.
Shapeshifting involves an altogether different and more subtle mechanism than conventional drugs, which stop the proteins working completely. The team behind SID – developed entirely at Strathclyde over the last decade, and now being deployed exclusively in collaboration with US firm Serometrix – will apply it to drug discovery for a wide range of diseases and conditions.
Dr Mark Dufton, of Strathclyde’s Department of Pure and Applied Chemistry, said: “Conventional drug discovery is extremely expensive, time consuming and often heavily reliant on ‘lottery techniques’ to identify useful drugs by chance.
“While this has certainly reaped benefits before, these traditional methods are becoming less fruitful and many new drug candidates found in this way are being abandoned because of toxicity problems and side effects. Drugs that act by shapeshifting work in a much smarter way that is a closer mimic of natural mechanisms for control.
“The ability of SID to predict the scope for ‘shapeshifting’ enables us to probe large, complex biological molecules – which have evolved their intricate shapes over hundreds of millions of years – so that we can analyse where and whether they can be targeted to provide treatments. When targeting is more selective, and the mechanism is smarter, a new generation of better medicines beckons.
“There are thousands of different types of protein in the human system that cooperate and regulate each other so that we can function properly. Nature has evolved a beautifully intricate set of mechanisms that regulate many of our critical functions by simply changing protein shape.
“In simple terms, these ‘shapeshifter’ mechanisms allow the proteins to modulate their biological activity by changing their surface character, rather like tectonic plates moving around the surface of the Earth. The more we understand these mechanisms, the more we can emulate what nature has already developed so elegantly.
“Diseases are often caused by certain molecules in the body being either too active or not active enough – or by them operating in the wrong place at the wrong time. The new technology helps discovery of ‘shapeshifting’ drugs that can carefully adjust these biological molecules, bringing them under control and thus less likely to cause problems.
“We can use this knowledge, in the case of a specific disease, to help a key protein be more or less active when the system is not working optimally on its own.”
Strathclyde Professor of Medicinal Chemistry & Drug Discovery Portal Director, Simon Mackay added: “This is an exciting step towards rapidly and efficiently designing the next wave of innovative pharmaceuticals.”
Dr John Wilson, of Strathclyde’s Department of Computer and Information Sciences, said: “We’ve been able to understand how to optimise the SID algorithm such that it now provides a near real-time, three-dimensional, graphical output that makes it extremely easy for clients to quickly understand where to focus their efforts.”
Serometrix Chief Executive Officer Mike Muehlemann said SID was already yielding promising early leads in the search for potential treatments for hypercholesterolemia – high cholesterol – and cardiovascular disease. He added: “Drug discovery and development represents one of the toughest technical challenges of our times.
“We have partnered with Strathclyde because their SID technology is best-in-class and fits exceedingly well with our own technology. The promise of better pharmaceuticals at lower cost is a lofty goal but it is one we believe we can achieve.
“With this combination of technologies we expect to reduce the number of early trial compounds from millions to hundreds, potentially shaving years off the discovery-development programme. Even though regulatory costs may remain high or escalate, an increased yield has the potential for significant cost reduction in the resulting pharmaceuticals.”
The Latest Bing News on:
Shapeshifting computer program
- New computer algorithm supercharges climate models and could lead to better predictions of future climate changeon May 1, 2024 at 11:00 am
Earth System Models—complex computer models that describe Earth processes and how they interact—are critical for predicting future climate change. By simulating the response of our land, oceans and ...
- Computer Programming and Data Analysis for Dummieson April 30, 2024 at 3:33 pm
A new CEE class explores how a ChatGPT plugin removes entry barriers to the Wolfram family of data analysis tools for students in any discipline ...
- Software dev joins ranks of history's greatest monsters by adding microtransactions to the original Doomon April 30, 2024 at 8:46 am
Such is the bold vision of Guy Dupont, a developer whose recent entry into the Boston Stupid Shit Nobody Needs and Terrible Ideas Hackathon was the most sacrilegious gag I've ever seen: He added ...
- Best Online Computer Science Programs of 2024on April 25, 2024 at 5:00 pm
Online computer science programs let you earn a degree that can lead to a new job or higher pay. See our picks for the best online computer science degree.
- Cornell University Pioneers Groundwork for Public Good as Empire AI Era Dawnson April 24, 2024 at 10:23 pm
Nutrition in the West is a young discipline – only 100 years old. Artificial intelligence is even newer. Combining the two could create a powerful tool to customize health advice, instead of the ...
- Computer vision researcher develops privacy software for surveillance videoson April 24, 2024 at 5:00 pm
Computer vision can be a valuable tool for anyone tasked with analyzing hours of footage because it can speed up the process of identifying individuals. For example, law enforcement may use it to ...
- This amazing, surprising browser game shows the Internet can still be magicalon April 19, 2024 at 8:52 am
Treat yourself to a magical internet experience with free sci-fi game Corru.Observer, playable in your browser.
- Here are 14 of the best self-driving cars from TV and filmon January 4, 2024 at 9:13 pm
mildly ironic when VW is looking for its autonomous driving software to be 'accident-free'. (Image - Walt Disney Productions, Dir: Robert Stevenson) Shapeshifting from 1976 ... us back to the land of ...
The Latest Google Headlines on:
Shapeshifting computer program
[google_news title=”” keyword=”Shapeshifting computer program” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Drug discovery
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
The WEHI research team paired venetoclax, a current standard-of-care anti-cancer drug for AML, with a STING agonist, an emerging class of immunotherapy drugs. Venetoclax was based on a landmark ...
- Bloodsucking fly behind ‘new drug discovery’on May 1, 2024 at 12:11 am
Researchers at the University of Sydney have discovered a potentially “game-changing” new drug capable of preventing blood clots and fatal bleeding during surgery – thanks to the bloodsucking African ...
- NYC-based AI drug discovery company moves HQ to Cambridgeon April 30, 2024 at 6:57 am
If you are not in Boston, you are not in biotech, in my opinion,” said the founder of Insilico, a 10-year-old AI drug discovery company that's moving its headquarters from New York to Massachusetts.
- Xaira Launches with $1 Billion to Pioneer AI-Driven Drug Discoveryon April 28, 2024 at 11:36 pm
Xaira Therapeutics, an AI drug discovery startup, recently launched with a remarkable $1 billion funding, backed by prominent investors like ARCH Venture Partners and Foresite Labs. The company, led ...
- A Pharmaceutical Company is Working to Speed Up the Drug Development Process with AIon April 28, 2024 at 9:50 pm
Algorae Pharmaceuticals is finding ways to revamp its process of drug development from cost saving and speed to timeline of drug research and delivery by ...
- Drug Discovery Services Market To Reach USD 75.3 Billion By 2032, Says DataHorizzon Researchon April 27, 2024 at 6:31 am
The drug discovery services market size was valued at USD 20.8 Billion in 2023 and is expected to reach a market size of USD 75.3 Billion by 2032 at a CAGR of 15.4%.Fort Collins, Colorado, April 27, ...
- This Biotech Startup Aims To Speed Up Drug Testing On Animalson April 26, 2024 at 3:29 am
Gordian Biotechnology’s platform allows for potentially hundreds of gene therapies to be tested in an animal at the same time — without harming it.
- Using Explainable AI To Ensure Drug Discovery Safetyon April 25, 2024 at 5:00 pm
Can you discuss the significance of this for drug discovery/ development? SW: Safety is a huge cause of failure, 56% of projects are failing from preclinical trials onwards due to safety. Yet, when we ...
- A shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteinson April 25, 2024 at 11:00 am
For most human proteins, there are no small molecules known to bind them chemically (so-called "ligands"). Ligands frequently represent important starting points for drug development but this ...
- The Difference Is the Data: Drug Discovery’s AI Revolutionon April 25, 2024 at 4:00 am
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
The Latest Google Headlines on:
Drug discovery
[google_news title=”” keyword=”drug discovery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]